RxDoctor Payments Data

Alvin He

Physician Assistant · Brooklyn, NYNPI 1073897559

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AbbVie at 32.6% of the total. Reporting peaked in 2022 at $1,193 and has fallen 68.3% since, to $378 in 2025. Among physician assistant clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,172in general payments, 2019–2025

Across 98 payments — averaging $42.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Gilead$894
  • Esperion Therapeutics, Inc.$668
  • Boehringer Ingelheim$246
  • Pfizer$241
  • Angiodynamics, Inc.$135
  • plus $626 from 11 others

What the payments were for

  • Food & beverage$4,172100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,172 in reported general payments places this provider in the 90th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York →

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase63$107,849
NexiumEsomeprazole Magnesium136$38,642
ZenpepLipase/Protease/Amylase16$28,621
LinzessLinaclotide45$27,760
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates188$11,681
DexilantDexlansoprazole31$8,993
Dexlansoprazole DrDexlansoprazole26$4,668
Mesalamine19$3,616
Sucralfate83$3,024
Lansoprazole116$1,533
Pantoprazole Sodium294$1,410
Famotidine99$1,186
Clarithromycin20$748
Dicyclomine Hcl111$652
Omeprazole58$504

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess$1,362$135,609108 claims
Aimmune Therapeutics, Inc.Zenpep$28$28,62116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Brooklyn

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →